Stifel Backs Cooper Companies (COO) as CooperSurgical Sale Talks Progress
Key takeaways
- This stock is backed by 49 hedge funds, and analysts see the stock rising at least 17% from its current price in the next 12 months.
- On June 12, Stifel reiterated a Buy rating on Cooper Companies Inc (NASDAQ:COO) stock with a price target of $85 on the shares.
- Stifel remarked that the settlement is a signal that the management is advancing the unit sale talks to the next level.
Stifel Backs Cooper Companies (COO) as Cooper Surgical Sale Talks Progress Abdul Rahman Sat, June 27, 2026 at 12:50 AM GMT+7 2 min read COO Cooper Companies Inc (NASDAQ:COO) is one of the best stocks to buy according to Billionaire Barry Rosenstein. This stock is backed by 49 hedge funds, and analysts see the stock rising at least 17% from its current price in the next 12 months.
On June 12, Stifel reiterated a Buy rating on Cooper Companies Inc (NASDAQ:COO) stock with a price target of $85 on the shares. The brokerage made this call after Cooper reported advancing discussions to sell its surgical business unit known as CooperSurgical. The company said multiple parties are interested in buying the business. The company also settled all legal issues that had plagued the business unit.
Stifel remarked that the settlement is a signal that the management is advancing the unit sale talks to the next level. Selling CooperSurgical would leave Cooper focused on the contact lens business under its CooperVision unit.